Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases

Surgery

Volumn 143, Issue 5, 2008, Pages 648-657

  Tamandl, Dietmar ^a   Herberger, Beata ^a   Gruenberger, Birgit ^a   Schoppmann, Sebastian F ^a   Puhalla, Harald ^a   Schindl, Martin ^a   Schima, Wolfgang ^a   Jakesz, Raimund ^a   Gruenberger, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; PATIENT MONITORING; PEROPERATIVE ECHOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL PATIENT; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; AGED; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LAPAROTOMY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSPECTIVE STUDIES;

EID: 43049104119     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.11.020     Document Type: Article

References (36)

1. Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318 discussion 318-21
2. Khatri V.P., Petrelli N.J., and Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol 23 (2005) 8490-8499
3. Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 6 (2006) 33-42
4. Regge D., Campanella D., Anselmetti G.C., Cirillo S., Gallo T.M., Muratore A., et al. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol 61 (2006) 338-347
5. Bipat S., van Leeuwen M.S., Comans E.F., Pijl M.E., Bossuyt P.M., Zwinderman A.H., et al. Colorectal liver metastases: CT, MR imaging, PET for diagnosis-meta-analysis. Radiology 237 (2005) 123-131
6. Leen E., Ceccotti P., Moug S.J., Glen P., MacQuarrie J., Angerson W.J., et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?. Ann Surg 243 (2006) 236-240
7. Zacherl J., Scheuba C., Imhof M., Zacherl M., Langle F., Pokieser P., et al. Current value of intraoperative sonography during surgery for hepatic neoplasms. World J Surg 26 (2002) 550-554
8. Gruenberger T., Jourdan J.L., Zhao J., King J., and Morris D.L. Echogenicity of liver metastases is an independent prognostic factor after potentially curative treatment. Arch Surg 135 (2000) 1285-1290
9. Gruenberger T., Zhao J., King J., Chung T., Clingan P.R., and Morris D.L. Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy. Cancer 94 (2002) 1753-1759
10. Van Etten B., Van der Sisp J., Kruyt R., Dudkerk M., Van der Holt B., and Wiggers T. Ferrumoxide-enhanced magnetic resonance imaging techniques in preoperative assessment for colorectal liver metastases. Eur J Surg Oncol 28 (2002) 645-651
11. Digumarthy S., Suhani D., and Saini S. MRI detection of hepatocellular carcinoma (HCC). Cancer Imaging 5 (2005) 20-24
12. Conlon R., Jacobs M., Dasgupta D., and Lodge J.P. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 16 (2003) 211-216
13. Jarnagin W.R., Bach A.M., Winston C.B., Hann L.E., Heffernan N., Loumeau T., et al. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease?. J Am Coll Surg 192 (2001) 577-583
14. Cervone A., Sardi A., and Conaway G.L. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 66 (2000) 611-615
15. Benoist S., Brouquet A., Penna C., Julie C., El Hajjam M., Chagnon S., et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol 24 (2006) 3939-3945
16. Morise Z., Sugioka A., Fujita J., Hoshimoto S., Kato T., Hasumi A., et al. Does repeated surgery improve the prognosis of colorectal liver metastases?. J Gastrointest Surg 10 (2006) 6-11
17. Trillet-Lenoir V., Freyer G., Kaemmerlen P., Fond A., Pellet O., Lombard-Bohas C., et al. Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria. Br J Radiol 75 (2002) 903-908
18. Adam R., Pascal G., Castaing D., Azoulay D., Delvart V., Paule B., et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg 240 (2004) 1052-1061 discussion 1061-4
19. Tamandl D., Gruenberger B., Herberger B., Schoppmann S.F., Bodingbauer M., Schindl M., et al. Selective resection of colorectal liver metastases. EJSO 33 (2007) 174-182
20. Lamb G., and Taylor I. An assessment of ultrasound scanning in the recognition of colorectal liver metastases. Ann R Coll Surg Engl 64 (1982) 391-393
21. Weg N., Scheer M., and Gabor M. Liver lesions: Improved detection with dual detector array CT and routine 2.5mm thin collimation. Radiology 209 (1998) 417-426
22. Abdelmoumene A., Chevallier P., Chalaren M., Schneider F., Verdun F., and Denys A. Detection of liver metastases under 2 cm: Comparison of different acquisition protocols in 4 row multidetector CT. Eur Radiol 15 (2005) 1881-1887
23. Ward J., Robinson P.J., Guthrie J.A., Downing S., Wilson D., Lodge J.P., et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237 (2005) 170-180
24. Fong Y., Saldinger P.F., Akhurst T., Macapinlac H., Yeung H., Finn R.D., et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178 (1999) 282-287
25. Truant S., Huglo D., Hebbar M., Ernst O., Steinling M., and Pruvot F.R. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 92 (2005) 362-369
26. Wiering B., Ruers T.J., Krabbe P.F., Dekker H.M., and Oyen W.J. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Ann Surg Oncol 14 (2007) 818-826
27. Wiering B., Krabbe P.F., Dekker H.M., Oyen W.J., and Ruers T.J. The role of FDG-PET in the selection of patients with colorectal liver metastases. Ann Surg Oncol 14 (2007) 771-779
28. Akhurst T., Kates T.J., Mazumdar M., Yeung H., Riedel E.R., Burt B.M., et al. Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 23 (2005) 8713-8716
29. Jarnagin W.R., Conlon K., Bodniewicz J., Dougherty E., DeMatteo R.P., Blumgart L.H., et al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91 (2001) 1121-1128
30. Jarnagin W.R., Fong Y., Ky A., Schwartz L.H., Paty P.B., Cohen A.M., et al. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg 188 (1999) 33-42
31. Grobmyer S.R., Fong Y., D'Angelica M., Dematteo R.P., Blumgart L.H., and Jarnagin W.R. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg 139 (2004) 1326-1330
32. Jarnagin W.R., Bodniewicz J., Dougherty E., Conlon K., Blumgart L.H., and Fong Y. A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg 4 (2000) 34-43
33. Kemeny N., Huang Y., Cohen A.M., Shi W., Conti J.A., Brennan M.F., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341 (1999) 2039-2048
34. Karoui M., Penna C., Amin-Hashem M., Mitry E., Benoist S., Franc B., et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243 (2006) 1-7
35. Leonard G.D., Brenner B., and Kemeny N.E. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23 (2005) 2038-2048
36. Nordlinger B., Sorbye H., Collette L., Glimelius B., Poston G.J., Schlag P.M., et al. Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol (2007) ASCO Annual Meeting Proceedings Part I;25:LBA5